Capstone Holding Corp. (CAPS)
- Previous Close
5.20 - Open
5.20 - Bid 0.23 x 10000
- Ask 0.29 x 10000
- Day's Range
5.20 - 5.20 - 52 Week Range
4.90 - 37.00 - Volume
25 - Avg. Volume
0 - Market Cap (intraday)
819,572 - Beta (5Y Monthly) -0.58
- PE Ratio (TTM)
-- - EPS (TTM)
-31.27 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.
www.capstonethx.com46
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CAPS
Performance Overview: CAPS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAPS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAPS
Valuation Measures
Market Cap
1.10M
Enterprise Value
29.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.02
Price/Book (mrq)
0.30
Enterprise Value/Revenue
0.62
Enterprise Value/EBITDA
-17.13
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.90%
Return on Assets (ttm)
-1.33%
Return on Equity (ttm)
-12.23%
Revenue (ttm)
48.35M
Net Income Avi to Common (ttm)
-5.74M
Diluted EPS (ttm)
-31.27
Balance Sheet and Cash Flow
Total Cash (mrq)
17k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.45M
Company Insights: CAPS
CAPS does not have Company Insights